CN104873935A - 温肾养肝中药酒 - Google Patents
温肾养肝中药酒 Download PDFInfo
- Publication number
- CN104873935A CN104873935A CN201510261348.0A CN201510261348A CN104873935A CN 104873935 A CN104873935 A CN 104873935A CN 201510261348 A CN201510261348 A CN 201510261348A CN 104873935 A CN104873935 A CN 104873935A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- kidney
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 25
- 210000004185 liver Anatomy 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 235000014101 wine Nutrition 0.000 title claims abstract description 16
- 238000010792 warming Methods 0.000 title claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241000628997 Flos Species 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 10
- 241000756943 Codonopsis Species 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 30
- 208000008035 Back Pain Diseases 0.000 abstract description 18
- 208000008930 Low Back Pain Diseases 0.000 abstract description 18
- 206010003549 asthenia Diseases 0.000 abstract description 9
- 230000005906 menstruation Effects 0.000 abstract description 6
- 230000001939 inductive effect Effects 0.000 abstract description 5
- 208000002173 dizziness Diseases 0.000 abstract description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract description 3
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000490229 Eucephalus Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 206010028289 Muscle atrophy Diseases 0.000 abstract 1
- 239000006002 Pepper Substances 0.000 abstract 1
- 235000016761 Piper aduncum Nutrition 0.000 abstract 1
- 235000017804 Piper guineense Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- 240000001638 Scurrula parasitica Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000020097 white wine Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 23
- 230000036407 pain Effects 0.000 description 22
- 239000008280 blood Substances 0.000 description 19
- 230000007812 deficiency Effects 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 18
- 239000000796 flavoring agent Substances 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 18
- 230000006870 function Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 210000001624 hip Anatomy 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000004998 Abdominal Pain Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 6
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010050031 Muscle strain Diseases 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- 208000012886 Vertigo Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000000629 knee joint Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 231100000889 vertigo Toxicity 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- FBMORZZOJSDNRQ-GLQYFDAESA-N Atractylenolide III Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@@]1(O)C2=C(C)C(=O)O1 FBMORZZOJSDNRQ-GLQYFDAESA-N 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000000146 antalgic effect Effects 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 239000000052 vinegar Substances 0.000 description 4
- 235000021419 vinegar Nutrition 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 208000002881 Colic Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010016807 Fluid retention Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- PZZRDJXEMZMZFD-ODPGBAFUSA-N Reynoutrin Natural products O[C@H]1[C@H](O)[C@@H](O)CO[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O PZZRDJXEMZMZFD-ODPGBAFUSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- BDCDNTVZSILEOY-UXYNSRGZSA-N avicularin Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O BDCDNTVZSILEOY-UXYNSRGZSA-N 0.000 description 3
- QIARVOTYSDZZQL-UHFFFAOYSA-N avicularin Natural products OCC1OC(Oc2cc(O)c3C(=O)C(=C(Oc3c2)c4ccc(O)c(O)c4)O)C(O)C1O QIARVOTYSDZZQL-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- ALRFYJWUVHBXLV-UHFFFAOYSA-N guaijaverin Natural products OC1COC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O ALRFYJWUVHBXLV-UHFFFAOYSA-N 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- BDCDNTVZSILEOY-UHFFFAOYSA-N polystachoside Natural products OC1C(O)C(CO)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O BDCDNTVZSILEOY-UHFFFAOYSA-N 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- -1 quinone glycoside Chemical class 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- SYTGUXGLBXTALU-UHFFFAOYSA-N 2h-1,4-oxazine-3-carboxylic acid Chemical compound OC(=O)C1=NC=COC1 SYTGUXGLBXTALU-UHFFFAOYSA-N 0.000 description 2
- NESFDGDRYVANBC-UHFFFAOYSA-N 6-(hydroxymethyl)pyridin-3-ol Chemical compound OCC1=CC=C(O)C=N1 NESFDGDRYVANBC-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- FBMORZZOJSDNRQ-UHFFFAOYSA-N Demethoxy,B,HCl-Adriamycin Natural products C1C2C(=C)CCCC2(C)CC2(O)C1=C(C)C(=O)O2 FBMORZZOJSDNRQ-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 2
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 2
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 2
- 235000012976 tarts Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 2
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JVAZJLFFSJARQM-RMPHRYRLSA-N (2r,3r,4s,5s,6r)-2-hexoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JVAZJLFFSJARQM-RMPHRYRLSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- ABKPQICIFGNRAA-YCRPTBBLSA-N 5-[(e)-3-[3,5-dimethoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoxy]-3-methyl-5-oxo-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoic acid Chemical compound C=1C(OC)=C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C(OC)=CC=1\C=C\COC(=O)CC(C)(CC(O)=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ABKPQICIFGNRAA-YCRPTBBLSA-N 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- OQYBLUDOOFOBPO-UHFFFAOYSA-N Asterolide Natural products C1C2C(=C)CCCC2(C)CC2C1=C(C)C(=O)O2 OQYBLUDOOFOBPO-UHFFFAOYSA-N 0.000 description 1
- OQYBLUDOOFOBPO-KCQAQPDRSA-N Atractylenolide II Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@H]1C2=C(C)C(=O)O1 OQYBLUDOOFOBPO-KCQAQPDRSA-N 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- SFKSOXSKEWXFFN-YKORFWMPSA-N C(C)C(O)[C@@]1(O)[C@@H](O)[C@H](O)[C@H](O1)CO.C(C)C(O)[C@@]1(O)[C@@H](O)[C@H](O)[C@H](O1)CO Chemical compound C(C)C(O)[C@@]1(O)[C@@H](O)[C@H](O)[C@H](O1)CO.C(C)C(O)[C@@]1(O)[C@@H](O)[C@H](O)[C@H](O1)CO SFKSOXSKEWXFFN-YKORFWMPSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- YYSRTHIUABRSAB-UHFFFAOYSA-N Neocarthamin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C(O)C2=C1C(=O)CC(C=1C=CC(O)=CC=1)O2 YYSRTHIUABRSAB-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- JVAZJLFFSJARQM-UHFFFAOYSA-N O-n-hexyl beta-D-glucopyranoside Natural products CCCCCCOC1OC(CO)C(O)C(O)C1O JVAZJLFFSJARQM-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- YSKVBPGQYRAUQO-UZSYLJJSSA-N Schottenol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 YSKVBPGQYRAUQO-UZSYLJJSSA-N 0.000 description 1
- YSKVBPGQYRAUQO-UHFFFAOYSA-N Schottenol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CCC21 YSKVBPGQYRAUQO-UHFFFAOYSA-N 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- VDIQGOWLVYFDOU-UHFFFAOYSA-H [Ca+]O.[Ca+]O.[Ca+]O.[O-]P([O-])([O-])=O Chemical compound [Ca+]O.[Ca+]O.[Ca+]O.[O-]P([O-])([O-])=O VDIQGOWLVYFDOU-UHFFFAOYSA-H 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- OQYBLUDOOFOBPO-YDHLFZDLSA-N atractylenolide II Natural products CC1=C2C[C@H]3C(=C)CCC[C@@]3(C)C[C@@H]2OC1=O OQYBLUDOOFOBPO-YDHLFZDLSA-N 0.000 description 1
- OAXKIRPCKWQWOQ-UHFFFAOYSA-N atractylenolide III Natural products CC1=C2CC3C(CCCC3=C)CC2(O)OC1=O OAXKIRPCKWQWOQ-UHFFFAOYSA-N 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- YSKVBPGQYRAUQO-UBCZCFGNSA-N delta7 Stigmastenol Natural products O[C@@H]1C[C@@H]2[C@@](C)([C@@H]3C([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)=CC2)CC1 YSKVBPGQYRAUQO-UBCZCFGNSA-N 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 description 1
- MFVJCHSUSSRHRH-UHFFFAOYSA-N friedeline Natural products CC1(C)CCC2(C)CCC3C4(C)CCC5C(C)(C)C(=O)CCC5(C)C4CCC3(C)C2C1 MFVJCHSUSSRHRH-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- JVAZJLFFSJARQM-YBXAARCKSA-N n-Hexyl-beta-D-glucopyranoside Natural products CCCCCCO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JVAZJLFFSJARQM-YBXAARCKSA-N 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- UBFTZAGDGOMJQE-SACPXRHSSA-N neocarthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C(O)=CC2=C1C(=O)C[C@@H](C=1C=CC(O)=CC=1)O2 UBFTZAGDGOMJQE-SACPXRHSSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229950007908 piconol Drugs 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 1
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 1
- ABKPQICIFGNRAA-MLUXTLINSA-N tangshenoside I Natural products COc1cc(C=CCOC(=O)C[C@](C)(CC(=O)O)O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)cc(OC)c1O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O ABKPQICIFGNRAA-MLUXTLINSA-N 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗温肾养肝的中药药酒,其原料药材分别是:肉桂180份、生牡蛎180份、吴茱萸180份、紫菀180份、款冬花180份、胡椒180份、川续断180份、制草乌200份、红花200份、细辛200份、桑寄生200份、党参200份、干姜200份、龙骨200份、杜仲250份、生地黄200份、当归200份、黄芪200份、川芎300份、枸杞子300份、薄荷200份、白酒6000份,本发明所述治疗温肾养肝的中药酒,本产品对于肾虚腰痛、头目眩晕、通经止痛、腰肌劳损具有疗效确切。
Description
技术领域
本发明涉及中药酒领域,具体涉及由中药原料与酒配伍制成的养生中药酒。本产品具有温经止痛、补血驱寒的功效。用于肾虚腰痛、头目眩晕、通经止痛、腰肌劳损疗效确切。
背景技术
腰痛是以腰部一侧或两侧疼痛为主要症状的一种病证。西医的肾脏疾病、风湿病、腰肌劳损、脊椎及脊髓疾病等所致腰痛,可参照该证辨证论治。缠腰疼痛多由肾阳不足,寒凝带脉,或肝经湿热侵及带脉,经行之际,阳虚气弱,以致带脉气结不通而出现疼痛;或冲任气血充盛,以致带脉壅滞,湿热滞留而疼痛。中医对腰痛的认识较为深刻,在中医医书中常有“气滞腰痛”、“血瘀腰痛”、“寒湿腰痛”,以及“闪腰”、“虚劳”等的描述。传统医学不单纯着眼于腰痛的局部,而且认为腰痛与气血、经络、脏腑等功能有着十分密切的联系。中医学认为,产生腰痛的病因主要有以下几种类型:急性闪挫,气血淤滞型:这类腰痛是常因外力的击扑闪挫、跌打损伤引起。外伤导致经络损伤、气滞血淤,从而产生疼痛如锥,痛有定处。气血阻于腰间,不能输送下肢,而见下肢麻痛相间,日久筋失所养,见肢软无力,肉萎不红等症状,多常见痛。外感风寒湿邪,经络痹塞型:这类腰痛是因为风寒湿邪客于膀胱经及督脉后,造成气血凝滞,脉络不通所致。患者可因不同的诱发因素表现为腰膝冷痛、下肢重着、走串麻痛等多种症状。久病劳损,肾虚型:这类腰痛患者多为年龄较大、病程较久、体质较差。中医学认为,“腰者肾之府”。“凡腹痛悠悠戚戚,屡发不已者,肾之虚也”。这种腰痛常因七情内伤、房事不节,或年老体衰、肾气亏损,不运行,筋脉失养所致。
发明内容
本发明的目的在于提供一种温经止痛、补血驱寒的功效的内服中药酒。用于肾虚腰痛、头目眩晕、通经止痛、腰肌劳损疗效确切。
本发明的技术方案:
本发明所述治疗温肾养肝的原料药材是经过发明人进行大量摸索总结得出的,各组份配伍合理,具有较好的效果。
为达到减轻疼痛、缓解症状的功效,本发明选择:肉桂180份、生牡蛎180份、吴茱萸180份、紫菀180份、款冬花180份、胡椒180份、川续断180份、制草乌200份、红花200份、细辛200份、桑寄生200份、党参200份、干姜200份、龙骨200份、杜仲250份、生地黄200份、当归200份、黄芪200份、川芎300份、枸杞子300份、薄荷200份、白酒6000份;以上方所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相须、相使作用显著,具有提高免疫力作用,从而能够有效用于肾虚腰痛、头目眩晕、通经止痛、腰肌劳损等症。本发明选取的原料中药材中,其功效和药理作用分别是:
肉桂:性味:性大热,味辛、甘。功能:补火助阳,引火归源,散寒止痛,活血通经。暖脾胃,除积冷,通血脉。治命门火衰,肢冷脉微,亡阳虚脱,腹痛泄泻,寒疝奔豚,腰膝冷痛,经闭症瘕,阴疽,流注,及虚阳浮越,上热下寒。主治:用于阳痿、宫冷、心腹冷痛、虚寒吐泻、经闭、痛经、温经通脉。
生牡蛎:【性味与归经】咸,微寒。归肝、胆、肾经。【功效】平肝潜阳;重镇安神;软坚散结;收敛固涩。具有滋阴、养血、补五脏、活血、充肌等功效。1.益阴潜阳。用于阴虚阳亢引起的烦躁。失眠、头晕头痛、耳鸣目眩、潮热盗汗。收敛固涩。治疗虚汗、滞下、遗精。3.软坚散结。可治疗结肿、包块、痰火瘰疬。男子常食牡蛎可提高性功能及精子的质量。对男子遗精、虚劳乏损、肾虚阳痿等有较好的效果。体质虚弱儿童,肺门淋巴结核,颈淋巴结核,瘰疬者宜食;阴虚烦热失眠,心神不安者宜食;癌症患者及放疗、化疗后宜食。
吴茱萸:【性味归经】辛、苦,热;有小毒。归肝、脾、胃、肾经。【功能主治】散寒止痛,降逆止呕,助阳止泻。用于厥阴头痛,寒疝腹痛,寒湿脚气,痛经,经行腹痛,脘腹胀痛,呕吐吞酸,五更泄泻,外治口疮;高血压。
紫菀:性味:苦,温。功能主治:温肺,下气,消痰,止咳。治风寒咳嗽气喘,虚劳咳吐脓血,喉痹,小便不利。
款冬花:为双子叶植物药菊科植物款冬的花蕾。【功效】:润肺下气,化痰止嗽。【主治】:治咳逆喘息,喉痹。【性味归经】:辛,温。①《本经》:″味辛,温。″②《别录》:″甘,无毒。味微苦略辛,性平。″
胡椒:性味味辛,性热。归经归胃、大肠经。功效温中散寒,下气,消痰。主治腹痛泄泻,食欲不振,癫痫痰多。
川续断:性味归经:苦、辛,微温。归肝,肾经。功能主治:本种根入药,有行血消肿、生肌止痛、续筋接骨、补肝肾、强腰膝、安胎的功效。强筋骨,利关节,止崩漏。用于腰膝酸痛,风湿关节痛,骨折,跌打损伤,先兆流产,崩漏,带下病,遗精,尿频。活血祛瘀。调血脉。
制草乌:【功能主治】祛风除湿,温经止痛。用于风寒湿痹,关节疼痛,心腹冷痛,寒疝作痛,麻醉止痛。
红花:【化学成分】含红花甙、新红花甙、红花醌甙、红花多糖、棕榈酸、肉桂酸、月桂酸。【性味】性温,味辛。【功能主治】活血通经,散淤止痛,用于闭经,痛经,恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。
细辛:北细辛,,主治:祛风,散寒,行水,开窍。治风冷头痛,鼻渊,齿痛,痰饮咳逆,风湿痹痛。
桑寄生:【化学成分】枝、叶含广寄生甙即蒿蓄甙(avicularin),并含槲皮素(quercetin)等。【功能主治】补肝肾;强筋骨;祛风湿;安胎。主腰膝酸痛;筋骨痿弱;肢体偏枯;风湿痹痛;头错目眩;胎动不安,崩漏下血。用于风湿痹痛,腰膝酸软,筋骨无力,崩漏经多,妊娠漏血,胎动不安;高血压。
党参:具有补中益气,健脾益肺的功效。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴等。性味归经:性平,味甘、微酸。归脾、肺经。化学成分:党参含三萜类化合物无羁萜(friedelin)、蒲公英萜醇乙酸酯、α-菠甾醇及其葡萄糖甙、Δ7-豆甾烯醇及其葡萄糖甙、菠甾酮(spinesterone)。另含苍术内酯III(atractylenolide III),苍术内酯II(atractylenolide II),丁香醛(syringaldehyde),丁香甙(syringin),香草酸(vanillic acid),5-羟基-2-吡啶甲醇(5-hydroxy-2-pyridinemethanol)、α-呋喃羧酸(α-furancarboxylic acid)、正己基-葡萄糖甙(n-hexyl-β-D-glucopyranoside)、乙基-α-D-呋喃果糖甙(ethyl-α-D-fructofuranoside),以及烟酸、4种杂多糖及单糖等。尚含党参甙I、党参内酯和党参酸。
干姜:【性味、归经】味辛,性热。归脾、胃、心、肺经。【功效】温中散寒,回阳通脉,燥湿消痰,温肺化饮。【主治】脘腹冷痛;呕吐;泄泻,亡阳厥逆;寒饮喘咳;寒湿痹痛。
阳厥逆;寒饮喘咳;寒湿痹痛。
龙骨:【化学成分】:主含羟基磷酸钙Ca5(PO4)3(OH)(羟磷灰石);尚含少量碳酸钙及铁、铝、镁、锰、锶等元素;【性味】:甘涩,平。【归经】:入心、肝、肾、大肠经。【功能主治】:重镇安神镇惊安神,敛汗固精,止血涩肠,生肌敛疮。治惊痫癫狂,怔忡健忘,失眠多梦,自汗盗汗,遗精淋浊,吐衄便血,崩漏带下,泻痢脱肛,溃疡久不收口。
杜仲:甘微辛,温。入肝、肾经。具有补肝肾、壮腰膝、强筋骨、安胎的功效。治腰脊酸疼,足膝痿弱,小便余沥,阴下湿痒,胎漏欲堕,胎动不安,高血压。对免疫系统、内分泌系统、中枢神经系统、循环系统和泌尿系统都有不同程度的调节作用,杜仲能兴奋垂体-肾上腺皮质系统,增强肾上腺皮质功能。
生地黄:味甘、苦,性寒.入心、肝、肾经。【功效】清热生津滋阴,养血。【主治】治阴虚发热,消渴,吐血,衄血,血崩,月经不调,胎动不安,阴伤便秘。清热凉血,养阴,生津;用于热病烦渴、发斑发疹、阴虚内热、吐血、衄血、糖尿病、传染性肝炎。
当归:【化学成分】含基本内酯、正丁烯酰内酯、阿魏酸、烟酸、蔗糖和多种氨基酸,以及倍半萜类化合物等。【性味归经】性温,昧甘、辛。归肝、心、脾经。【功能主治】补血活血,调经止痛,润肠通便。用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
黄芪:具有1、表虚自汗,多用于体虚表弱所致的自汗。2、阴虚盗汗;3、急性肾炎水肿,用于阳气不足所致的虚性水肿;4、慢性肾炎水肿、脾肾虚者;5、阳气虚弱,用于疮疡久不溃破而内陷,有促进溃破及局限作用。6、疮疡久溃不愈,用于疮疡溃破后,久不收口,有生肌收口之作用;7、脾气虚证,虚弱倦怠,泄泻,中气下陷,脏器脱垂,食少纳呆诸症。8、肺气虚证。咳喘日久,气短神疲,痰雍于肺无力咯出。9、多汗而浮肿。10、用于气虚衰弱,倦怠乏力,或中气下陷、脱肛、子宫脱垂。性味:甘,微温。归经:归肺、脾、肝、肾经;有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。
川芎:味辛,性温。归肝、胆、心包经。【功能与主治】活血行气,祛风止痛。用于安抚神经,正头风头痛,症瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
枸杞子:【性味】甘,平。【归经】归肝、肾经。【功能主治】滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。
薄荷:【性味归经】辛,凉。归肝肺经。【功效】疏散风热,清利头目,透疹。【应用】具有疏散风热、清利头目、利咽、透疹、疏肝解郁之功效。现代医学常将其用于治疗风热感冒、头痛、咽喉痛、口舌生疮、风疹、麻疹、胸腹胀闷和抗早孕等。另外,薄荷还具有止痛作用。
白酒:减痛:不慎将脚扭伤后,将温白酒涂于伤处轻轻,能舒筋活血,清除疼痛。去腥:手上沾有鱼虾腥味时,用少许清洗,即可去掉腥气味。除腻:在烹调脂肪较多的肉类、鱼类时,加少许白酒,可使菜肴味道鲜美而不油腻。消苦:剖鱼时若弄破苦胆,立即在鱼肚内抹一点白酒,然后用冷水冲洗,可消除苦味。减酸:烹调菜肴时,如果加醋过多,只要再往菜中倒些白酒,可减轻酸味。去泡:因长途行走或因劳动摩擦手脚起泡时,临睡前把白酒涂于起泡处,次日晨可去泡。增香:往醋中加几滴白酒和少许食盐,搅拌均匀,既能保持醋的酸味,又能增加醋香味。
本发明所述治疗温肾养肝酒,其原料药材分别是:肉桂180份、生牡蛎180份、吴茱萸180份、紫菀180份、款冬花180份、胡椒180份、川续断180份、制草乌200份、红花200份、细辛200份、桑寄生200份、党参200份、干姜200份、龙骨200份、杜仲250份、生地黄200份、当归200份、黄芪200份、川芎300份、枸杞子300份、薄荷200份、白酒6000份;
其制备方法为以下步骤:步骤一)称取原料药材:肉桂180份、生牡蛎180份、吴茱萸180份、紫菀180份、款冬花180份、胡椒180份、川续断180份、制草乌200份、红花200份、细辛200份、桑寄生200份、党参200份、干姜200份、龙骨200份、杜仲250份、生地黄200份、当归200份、黄芪200份、川芎300份、枸杞子300份、薄荷200份;共研成细末,过筛混匀,备用;
步骤二)将以上各药与白酒,白糖同置于罐内,于水浴中加热煮沸后,在入缸中,密封,浸泡14日;
步骤三)浸泡14日后,滤取酒液,残渣压榨后回收残液中的酒液,合并过滤,贮瓶备用。
以上方所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相须、相使作用显著,具有提高免疫力作用。在治疗上能达到温经止痛、补血驱寒的功效。用于肾虚腰痛、头目眩晕、通经止痛、腰肌劳损疗效确切。临床应用时具有良好的效果。本发明中药酒的功效在临床应用当中得到了证实,基本资料如下:2003-2009年,门诊临床应用本发明所述中药酒对677例体验者用;平均年龄55岁;服用方法:每日早晚饭后饮用35-65ml;连续服用45-65日后,有效或显效589例;有效或显效的评价标准为:症状有所改善或者症状消失。
具体实施方法
本发明所述治疗温肾养肝酒,其原料药材分别是:肉桂180份、生牡蛎180份、吴茱萸180份、紫菀180份、款冬花180份、胡椒180份、川续断180份、制草乌200份、红花200份、细辛200份、桑寄生200份、党参200份、干姜200份、龙骨200份、杜仲250份、生地黄200份、当归200份、黄芪200份、川芎300份、枸杞子300份、薄荷200份、白酒6000份;
其制备方法为以下步骤:步骤一)称取原料药材:肉桂180份、生牡蛎180份、吴茱萸180份、紫菀180份、款冬花180份、胡椒180份、川续断180份、制草乌200份、红花200份、细辛200份、桑寄生200份、党参200份、干姜200份、龙骨200份、杜仲250份、生地黄200份、当归200份、黄芪200份、川芎300份、枸杞子300份、薄荷200份;共研成细末,过筛混匀,备用;
步骤二)将以上各药与白酒,白糖同置于罐内,于水浴中加热煮沸后,在入缸中,密封,浸泡14日;
步骤三)浸泡14日后,滤取酒液,残渣压榨后回收残液中的酒液,合并过滤,贮瓶备用。
Claims (1)
1.本发明所述治疗温肾养肝酒,其原料药材分别是:肉桂180份、生牡蛎180份、吴茱萸180份、紫菀180份、款冬花180份、胡椒180份、川续断180份、制草乌200份、红花200份、细辛200份、桑寄生200份、党参200份、干姜200份、龙骨200份、杜仲250份、生地黄200份、当归200份、黄芪200份、川芎300份、枸杞子300份、薄荷200份、白酒6000份;
其制备方法为以下步骤:步骤一)称取原料药材:肉桂180份、生牡蛎180份、吴茱萸180份、紫菀180份、款冬花180份、胡椒180份、川续断180份、制草乌200份、红花200份、细辛200份、桑寄生200份、党参200份、干姜200份、龙骨200份、杜仲250份、生地黄200份、当归200份、黄芪200份、川芎300份、枸杞子300份、薄荷200份;共研成细末,过筛混匀,备用;
步骤二)将以上各药与白酒,白糖同置于罐内,于水浴中加热煮沸后,在入缸中,密封,浸泡14日;
步骤三)浸泡14日后,滤取酒液,残渣压榨后回收残液中的酒液,合并过滤,贮瓶备用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510261348.0A CN104873935A (zh) | 2015-05-13 | 2015-05-13 | 温肾养肝中药酒 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510261348.0A CN104873935A (zh) | 2015-05-13 | 2015-05-13 | 温肾养肝中药酒 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104873935A true CN104873935A (zh) | 2015-09-02 |
Family
ID=53941790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510261348.0A Pending CN104873935A (zh) | 2015-05-13 | 2015-05-13 | 温肾养肝中药酒 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104873935A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114717072A (zh) * | 2022-05-18 | 2022-07-08 | 南通白蒲黄酒有限公司 | 一种驱寒暖胃的黄酒及制备方法 |
-
2015
- 2015-05-13 CN CN201510261348.0A patent/CN104873935A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114717072A (zh) * | 2022-05-18 | 2022-07-08 | 南通白蒲黄酒有限公司 | 一种驱寒暖胃的黄酒及制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100584369C (zh) | 一种外用治疗痹症中药组合物 | |
| CN101049437A (zh) | 一种外用治疗寒湿痹痛的膏剂 | |
| CN102772779A (zh) | 一种治疗痛经的药物及其制备方法 | |
| CN105194542A (zh) | 跌打中药酒 | |
| CN104758892A (zh) | 温经止痛活络酒 | |
| CN104623191A (zh) | 治疗心悸的中药酒 | |
| CN104474197A (zh) | 治疗心悸的中药酒 | |
| CN104958722A (zh) | 除湿止痹酒 | |
| CN104873935A (zh) | 温肾养肝中药酒 | |
| CN104740481A (zh) | 一种治疗功能性子宫出血的中药 | |
| CN104958720A (zh) | 祛痹止痛酒 | |
| CN105056130A (zh) | 骨伤中药酒 | |
| CN105106514A (zh) | 续断中药酒 | |
| CN104758893A (zh) | 舒肌健骨酒 | |
| CN104940341A (zh) | 通经止痛中药酒 | |
| CN106377644A (zh) | 一种治疗气血亏虚的中药组合物及制备方法 | |
| CN106389991A (zh) | 男科病的脐疗药物组合物、及其制作方法和用途 | |
| CN105012710A (zh) | 除湿止痹酒 | |
| CN104998241A (zh) | 黄芪益气中药酒 | |
| CN105168736A (zh) | 风湿止痛中药酒 | |
| CN105233204A (zh) | 阳和通脉中药酒 | |
| CN104337981A (zh) | 治疗遗精的中药制剂 | |
| CN105362804A (zh) | 一种治疗轻度贫血的中药组合物及其制备方法 | |
| CN104840726A (zh) | 一种可有效治疗席汉氏综合征的汤剂药物及制备方法 | |
| CN104740193A (zh) | 一种治疗颈肩肌肉劳损综合症的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150902 |
|
| WD01 | Invention patent application deemed withdrawn after publication |